First report of clinical and microbiological failure in the eradication of glycopeptide-intermediate methicillin-resistant Staphylococcus aureus carriage by mupirocin

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 5, 2003, Pages 318-319

  Decousser, J W ^a   Pina, P ^a   Ghnassia, J C ^a   Bedos, J P ^a   Allouch, P Y ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; GLYCOPEPTIDE; PSEUDOMONIC ACID; TEICOPLANIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; DRUG EFFECT; ERADICATION THERAPY; HAND WASHING; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0038548533     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0929-z     Document Type: Article

References (9)

1. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673
2. Guerin F, Buu-Hoi A, Mainardi JL, Kac G, Colardelle N, Vaupre S, Gutmann L, Podglajen I (2000) Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J Clin Microbiol 38:2985-2988
3. Centers for Disease Control and Prevention (2002) Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR 51:565-567
4. Boyce JM (2001) MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 48 [Suppl A]:9-14
5. Cookson BD (1998) The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 42:11-18
6. Comité de l'Antibiogramme de la Société Française de Microbiologie (2002) Communiqué 2002. Société Française de Microbiologie website, http://www.sfm.asso.fr/Sect4/com2002.pdf. Cited 31 December 2002
7. Allen GP, Cha R, Rybak MJ (2002) In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 46:2606-2612
8. Schmitz FJ, Lindenlauf E, Hofmann B, Fluit AC, Verhoef J, Heinz HP, Jones ME (1998) The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 42:489-495
9. Von Eiff C, Kipp F, Becker K (2002) Intranasal mupirocin to prevent postoperative infections. N Engl J Med 347:1207-1208